This report is being submitted in pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been able to investigate or verify prior to the required reporting date.This report does not reflect a conclusion by mitek or its employees that the report constitutes an admission that the device, mitek, or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.Device was used for treatment, not diagnosis.H10 additional narrative: h4: the device manufacture date is currently unavailable.Investigation summary : the complaint device was received at the service center and evaluated.During the service evaluation the following defects were identified: broken (2+ pieces) : chipped/shaved/delaminated, visual : damaged - unspecified.Per service reports, this complaint can be confirmed.The repair of the device was however declined, and it is being placed into long term hold.As part of depuy mitek¿s quality process all devices are manufactured, inspected, and released to approved specifications.The faulty parts was identified as the root cause for the device failure during the service evaluation.Additional complaint information monitoring for potential safety signals is conducted through complaint trending as part of post market surveillance.At this point in time, no corrective action is required, and no further action is warranted.Depuy mitek will continue to track any related complaints within this device family as a means of monitoring the extent with which this complaint is observed in the field.Udi:(b)(4).
|
It was reported by the healthcare professional that during testing on (b)(6) 2023, it was observed that the vapr vue wireless footswitch device stopped working and would not pair.During an in-house engineering evaluation, it was determined that the device was chipped/shaved/delaminated.The event did not occur during surgery.There was no patient involvement.There were no adverse patient consequences reported.No additional information was provided.
|